Evaxion Biotech to develop new vaccines for cancer

Evaxion Biotech has announced plans to develop customised cancer vaccines by targeting a category of AI-discovered tumour antigens.

Related Posts

STAT+: As AI promises to revolutionize medical note-tak...

Mar 28, 2023

Risk adjusted net present value: What is the current va...

Jul 2, 2024

STAT+: Alnylam reports growth in sales of rare disease ...

Aug 3, 2023